Biotechnology News Dysgeusia Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-4 out of 4 found

Current Search: dysgeusia: 4

Committee for Medicinal Products for Human Use Summary of Positive Opinion for Zevtera
International Nonproprietary Name (INN): ceftobiprole medocaril LONDON, Nov.

20, 2008-On 20 November 2008 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion,** recommending to grant a marketing...

Pharma Live: Nov 22 2008 3:24AM
Matching: dysgeusia

Find similar documents

GDC-0449 Well Tolerated in Patients With Advanced Solid Tumours: Presented at EORTC-NCI-AACR
-- Oral forms of the Hedgehog signalling inhibitor GDC-0449 are tolerated for extended periods of continuous dosing and demonstrate clinical efficacy in patients with locally advanced or metastatic solid malignancies.

Charles M.

Rudin,...

Doctors Guide: Nov 5 2008 12:29AM
Matching: dysgeusia

Find similar documents

Once-Daily Cethromycin Noninferior to Twice-Daily Clarithromycin in Treating Community-Acquired Pneumonia: Pre
-- Cethromycin once-daily achieved noninferiority to clarithromycin twice-daily in the treatment of community-acquired pneumonia, with similar safety results, researchers announced here at the 48th Annual Interscience Conference on...

Doctors Guide: Nov 1 2008 2:43AM
Matching: dysgeusia

Find similar documents

FDA Grants Full Approval to ONTAK (denileukin diftitox) for Use in Patients with Cutaneous T-Cell Lymphoma (CT
/PRNewswire/ - Eisai Corporation of North America announced today that the U.S.

Food and Drug Administration (FDA) has approved an efficacy supplemental biologics license application (sBLA) for ONTAK(R) (denileukin diftitox) solution for...

Pharma Live: Oct 16 2008 12:51PM
Matching: dysgeusia

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.